Riskpilot← Back to searchSign inGet full accessMSK AS
ASActiveOrg 990629056Ekebergveien 169, 1912 EnebakkRental and operating of own or leased real estate · NACE 6820Est. 20060 employees
Revenue 2024
NOK 0
EBITDA margin
—
-80% vs 2023
Equity ratio
70.1%
Financial strength
Net profit 2024
NOK 2,2M
-49% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -598K | -80% |
| Net profit | NOK 2,2M | -49% |
| Total assets | NOK 57M | +4% |
| Equity | NOK 39,9M | -27% |
| Employees | 0 | — |
Legal name
MSK AS
Org number
990629056
Legal form
Aksjeselskap
NACE code
6820 · Rental and operating of own or leased real estate
Founded
12. desember 2006
Share capital
NOK 323 190
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Investering i verdipapirer og fast eiendom.
Address
Ekebergveien 169, 1912 Enebakk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −322 | −363 | −327 | −332 | −598 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −322 | −363 | −327 | −332 | −598 |
| Net financials | 571 | 1 718 | −49 | 4 582 | 2 768 |
| Profit before tax | 249 | 1 356 | −375 | 4 250 | 2 170 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 249 | 1 356 | −375 | 4 250 | 2 170 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 57 419 | 52 752 | 50 597 | 54 849 | 56 961 |
| Equity | 52 557 | 50 912 | 50 537 | 54 787 | 39 927 |
| Long-term debt | 1 827 | 1 827 | 0 | 0 | 0 |
| Short-term debt | 3 036 | 13 | 60 | 62 | 17 034 |
| Total debt | 4 862 | 1 840 | 60 | 62 | 17 034 |
EBITDA margin
-59798600.0%
This company
15.8%
Market median
-378472252% vs market
20202024
Equity ratio
70.1%
This company
38.2%
Market median
+84% vs market
20202024
Return on equity
5.4%
This company
18.4%
Market median
-71% vs market
20202024
Net profit margin
217019300.0%
This company
8.1%
Market median
+2679250517% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.43×
This company
0.62×
Market median
+31% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2019 | |
| Chairman | 2019 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MSK AS 
REITEN & CO CAPITAL PARTNERS VII ASBoard members of MSK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nils Olav Fearnley Klaveness | Board of Directors | 0 companies |
| Mette Sommerschield Klaveness | Chairman | 0 companies |